These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 33902836)
1. Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial. Moussa G; Genest M; Villeneuve E; Wang JJ Ann Emerg Med; 2021 May; 77(5):555. PubMed ID: 33902836 [No Abstract] [Full Text] [Related]
2. Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial. Ruberto AJ; Sivilotti MLA; Forrester S; Hall AK; Crawford FM; Day AG Ann Emerg Med; 2021 Jun; 77(6):613-619. PubMed ID: 33160719 [TBL] [Abstract][Full Text] [Related]
3. A pilot study of intravenous ondansetron for hyperemesis gravidarum. Sullivan CA; Johnson CA; Roach H; Martin RW; Stewart DK; Morrison JC Am J Obstet Gynecol; 1996 May; 174(5):1565-8. PubMed ID: 9065130 [TBL] [Abstract][Full Text] [Related]
4. Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran). Tincello DG; Johnstone MJ Postgrad Med J; 1996 Nov; 72(853):688-9. PubMed ID: 8944215 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient: Case Report. La Sala MS; Constantino E; Koola MM; Yel I; Chacko M J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):506-508. PubMed ID: 35943399 [No Abstract] [Full Text] [Related]
12. Gaining Insight Into Ondansetron Safety in Early Pregnancy. Lavecchia M; Chari R; Ross S J Obstet Gynaecol Can; 2019 Apr; 41(4):419-420. PubMed ID: 30685231 [No Abstract] [Full Text] [Related]
13. Haloperidol for treatment of cannabinoid hyperemesis syndrome. Hickey JL; Witsil JC; Mycyk MB Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118 [TBL] [Abstract][Full Text] [Related]
14. Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy: A Systematic Review. McParlin C; O'Donnell A; Robson SC; Beyer F; Moloney E; Bryant A; Bradley J; Muirhead CR; Nelson-Piercy C; Newbury-Birch D; Norman J; Shaw C; Simpson E; Swallow B; Yates L; Vale L JAMA; 2016 Oct; 316(13):1392-1401. PubMed ID: 27701665 [TBL] [Abstract][Full Text] [Related]
15. Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome? Inayat F; Virk HU; Ullah W; Hussain Q BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28052951 [TBL] [Abstract][Full Text] [Related]
16. Ondansetrone or metoclopromide? Which is more effective in severe nausea and vomiting of pregnancy? A randomized trial double-blind study. Kashifard M; Basirat Z; Kashifard M; Golsorkhtabar-Amiri M; Moghaddamnia A Clin Exp Obstet Gynecol; 2013; 40(1):127-30. PubMed ID: 23724526 [TBL] [Abstract][Full Text] [Related]
17. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States. Fejzo MS; MacGibbon KW; Mullin PM Reprod Toxicol; 2016 Jul; 62():87-91. PubMed ID: 27151373 [TBL] [Abstract][Full Text] [Related]
18. Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review. Richards JR; Gordon BK; Danielson AR; Moulin AK Pharmacotherapy; 2017 Jun; 37(6):725-734. PubMed ID: 28370228 [TBL] [Abstract][Full Text] [Related]
19. Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis. Boelig RC; Barton SJ; Saccone G; Kelly AJ; Edwards SJ; Berghella V J Matern Fetal Neonatal Med; 2018 Sep; 31(18):2492-2505. PubMed ID: 28614956 [TBL] [Abstract][Full Text] [Related]
20. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery. Aouad MT; Siddik-Sayyid SM; Taha SK; Azar MS; Nasr VG; Hakki MA; Zoorob DG; Baraka AS Eur J Anaesthesiol; 2007 Feb; 24(2):171-8. PubMed ID: 16938159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]